AKT1 and renal cell carcinoma: In the signal pathway enrichment analysis, when P < 0.001 was adjusted, there were 35 coassociated pathways between the main target of RAC and RCC (Figure 2(c)), including the RCC-related PI3K/AKT/mTOR and MAPK pathway, and Table S1 displays the top 20 pathways.